Kathleen Durgin Kolstad, MD
Rheumatology · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 11
Offices
11 locations · The Regents of the University of California · 1,426 clinicians in this group
Hospitals listed: Goleta Valley Cottage Hospital · Santa Barbara Cottage Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kolstad’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A133255 · Current
Licensed to practise in California · since 2014 · expires 2028-08-31 · David Geffen School of Medicine at UCLA.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Goleta Valley Cottage HospitalSanta Barbara, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency departmentPart of Cottage Health System, which runs 4 hospitalsPatients rate it 4 of 5 · 85% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
- Santa Barbara Cottage HospitalSanta Barbara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Cottage Health System, which runs 4 hospitalsPatients rate it 4 of 5 · 85% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — SSI - Abdominal Hysterectomy: 4.13, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.43, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.54, Oct 2024 – Sep 2025
See every measure and the patient survey for Goleta Valley Cottage Hospital
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 3 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.05 (0 to 2.14) · 36 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.6 to 1.55) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 478 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,002 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 852 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.85 (0.46 to 5.24) · 586 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 393 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.55 (0.85 to 4.24) · 572 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.08 (5.76 to 24.4) · 402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.87 (0.68 to 9.05) · 383 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0 to 1.75) · 526 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 229 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 39 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -40.9 · 32 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.5 · 77 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 238 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 173 cases | No different | Jan 2024 – Dec 2024 |
What patients said (274 patients answered, 38% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 87% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 81% |
| Staff "always" explained new medications | 80% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 90% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 85% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Santa Barbara Cottage Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Abdominal HysterectomyInfections | 4.13 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.43 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.54 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.45 (0.62 to 2.28) · 2,441 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.7 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 177.7 (138.01 to 217.4) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.5 · 93 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 246 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.6 · 664 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 843 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.9 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,479 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0.01 to 0.36) · 11,271 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,702 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5 (3.35 to 6.65) · 3,316 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.12 (0 to 2.54) · 1,592 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.39 (1.15 to 3.63) · 3,116 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.63 (1.89 to 11.37) · 1,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (2.08 to 7.95) · 1,565 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.32 (0.93 to 3.71) · 836 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0.02 to 1.04) · 9,175 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 254 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.027 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.626 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.42 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 266 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 711 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.6 · 256 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -7.6 · 746 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -11.7 · 870 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 842 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.1 to 7.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (7.9 to 15.5) · 110 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 266 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.7 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 138 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 16.1 (12.4 to 21.2) · 510 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 577 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,306 patients answered, 29% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 81% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 85% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$533,606
Medicare paid this office $533,606 for 585 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 103 | $197,344 | None |
| Injection, romosozumab-aqqg, 1 mg | 20 | $187,111 | None |
| Return visit (30+ min) | 380 | $77,709 | $100 |
| New patient visit (45+ min) | 303 | $39,560 | $131 |
| Long return visit (40+ min) | 51 | $10,707 | $143 |
See all 12 services
| Injection, denosumab, 1 mg | 103 | $197,344 | None |
| Injection, romosozumab-aqqg, 1 mg | 20 | $187,111 | None |
| Return visit (30+ min) | 380 | $77,709 | $100 |
| New patient visit (45+ min) | 303 | $39,560 | $131 |
| Long return visit (40+ min) | 51 | $10,707 | $143 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 282 | $7,906 | $13 |
| New patient visit (60+ min) | 24 | $4,413 | $184 |
| Injection of drug or substance under skin or into muscle | 117 | $3,069 | $12 |
| Short return visit (20+ min) | 28 | $2,284 | $76 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $924 | $71 |
| Insertion of needle into vein for collection of blood sample | 55 | $624 | $9 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $493 | $45 |
Who their Medicare patients are
585 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 11% · Women 76% · Also on Medicaid 7% · Health risk score 1.13. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 60% · Depression 23% · Coronary heart disease 18% · Chronic kidney disease 18% · Diabetes 15% · Cancer 15% · Atrial fibrillation 15% · COPD 12% · Stroke 9% · Heart failure 8% · Dementia 2%.
The office billed $3,406,929, Medicare allowed $679,574 and paid $533,606; for 33,574 services of 20 kinds; $384,455 of it was for drugs given in the office and $149,152 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 585 | 33,574 | 75 | 1.13 | $3,406,929 | $533,606 |
| 2023 | 362 | 13,957 | 74 | 1.11 | $1,533,493 | $234,599 |
| 2022 | 274 | 2,140 | 73 | 1.18 | $682,948 | $93,690 |
| 2021 | 66 | 154 | 71 | 1.11 | $116,172 | $15,617 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 220 | $60,340 | $102 |
| Injection, denosumab, 1 mg | 30 | $50,067 | None |
| New patient visit (45+ min) | 212 | $28,116 | $133 |
| Long return visit (40+ min) | 26 | $5,285 | $151 |
| Short return visit (20+ min) | 44 | $3,151 | $64 |
| New patient visit (60+ min) | 13 | $2,102 | $162 |
| Injection of drug or substance under skin or into muscle | 41 | $1,120 | $12 |
| Insertion of needle into vein for collection of blood sample | 58 | $991 | $8 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $360 | $16 |
2022: 8 services
| Return visit (30+ min) | 130 | $31,439 | $107 |
| New patient visit (45+ min) | 193 | $24,948 | $129 |
| Injection, denosumab, 1 mg | 11 | $12,537 | None |
| Short return visit (20+ min) | 77 | $6,873 | $74 |
| Long return visit (40+ min) | 21 | $5,155 | $143 |
| New patient visit (60+ min) | 23 | $4,003 | $174 |
| Injection of drug or substance under skin or into muscle | 14 | $240 | $13 |
| Insertion of needle into vein for collection of blood sample | 26 | $154 | $3 |
2021: 2 services
| New patient visit (45+ min) | 44 | $6,226 | $142 |
| Return visit (30+ min) | 20 | $4,011 | $103 |
Medicaid work
$12,827 in 2021
Medicaid paid $12,827 for 195 billed services this clinician did in 2021, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 166 | $12,798 |
| Return visit (30+ min) | 29 | $28 |
| 2021 | 195 | 2 | 26 | $12,827 |
| 2020 | 43 | 2 | 24 | $1,660 |
See the largest Medicaid services in earlier years
2020
| Clinic visit/encounter, all-inclusive | 25 | $1,617 |
| Return visit (30+ min) | 18 | $43 |
Drugs they prescribed that Part D paid
$903,232
Pharmacies billed $903,232 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
719 generic and 189 brand-name prescriptions · $903,232 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 29 | $216,477 | $7,465 |
| Kevzara | 21 | $94,213 | $4,486 |
| Tymlos | 11 | $31,530 | $2,866 |
| Rasuvo | 13 | $8,590 | $661 |
| Hydroxychloroquine Sulfate | 90 | $4,903 | $54 |
See all 15 drugs
| Enbrel Sureclick | 29 | $216,477 | $7,465 |
| Kevzara | 21 | $94,213 | $4,486 |
| Tymlos | 11 | $31,530 | $2,866 |
| Rasuvo | 13 | $8,590 | $661 |
| Hydroxychloroquine Sulfate | 90 | $4,903 | $54 |
| Methotrexate | 109 | $3,499 | $32 |
| Prednisone | 259 | $3,463 | $13 |
| Sulfasalazine Dr | 48 | $3,169 | $66 |
| Colchicine | 19 | $1,924 | $101 |
| Celecoxib | 11 | $1,186 | $108 |
| Omeprazole | 18 | $372 | $21 |
| Alendronate | 31 | $368 | $12 |
| Gabapentin | 24 | $345 | $14 |
| Allopurinol | 25 | $172 | $7 |
| Pantoprazole | 13 | $133 | $10 |
Year by year
| 2024 | 908 | 222 | None | 21% | $903,232 |
| 2023 | 755 | 156 | None | None | $1,084,506 |
| 2022 | 362 | 84 | None | None | $655,938 |
| 2021 | 161 | 40 | 0% (0) | 19% | $492,736 |
| 2020 | 198 | 42 | 0% (0) | 11% | $49,538 |
| 2019 | 148 | 32 | 0% (0) | 16% | $77,115 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Enbrel Sureclick | 13 | $106,131 | $8,164 |
| Tymlos | 24 | $63,737 | $2,656 |
| Hydroxychloroquine Sulfate | 65 | $4,082 | $63 |
| Sulfasalazine Dr | 49 | $3,483 | $71 |
| Prednisone | 228 | $3,347 | $15 |
| Methotrexate | 38 | $1,035 | $27 |
| Omeprazole | 32 | $1,003 | $31 |
| Colchicine | 15 | $898 | $60 |
| Allopurinol | 45 | $853 | $19 |
| Diclofenac | 12 | $645 | $54 |
| Gabapentin | 20 | $609 | $30 |
| Pantoprazole | 15 | $277 | $18 |
| Azathioprine | 11 | $239 | $22 |
| Alendronate | 11 | $147 | $13 |
2022: 9 drugs
| Octagam | Immune globulin | 13 | $481,239 | $37,018 |
| Tymlos | None | 13 | $31,537 | $2,426 |
| Hydroxychloroquine Sulfate | None | 31 | $2,566 | $83 |
| Prednisone | None | 91 | $1,035 | $11 |
| Diclofenac | None | 16 | $875 | $55 |
| Sulfasalazine Dr | None | 12 | $532 | $44 |
| Methotrexate | None | 13 | $423 | $33 |
| Gabapentin | None | 18 | $235 | $13 |
| Allopurinol | None | 13 | $100 | $8 |
2021: 3 drugs
| Hydroxychloroquine Sulfate | 15 | $762 | $51 |
| Diclofenac | 26 | $749 | $29 |
| Prednisone | 22 | $331 | $15 |
2020: 4 drugs
| Hydroxychloroquine Sulfate | 27 | $3,428 | $127 |
| Methotrexate | 23 | $801 | $35 |
| Prednisone | 51 | $434 | $9 |
| Diclofenac | 15 | $333 | $22 |
2019: 4 drugs
| Methotrexate | 18 | $829 | $46 |
| Prednisone | 44 | $464 | $11 |
| Azathioprine | 11 | $464 | $42 |
| Nabumetone | 11 | $307 | $28 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2024 | 1 | 1 | None | $122 |
| 2022 | 4 | 5 | None | $346 |
| 2021 | 1 | 1 | None | $17 |
| 2020 | 1 | 1 | None | $81 |
| 2019 | 1 | 1 | None | $94 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Aurinia Pharma U.S. | Lupkynis | $125 | 1 payment
|
See the published payment
| Aurinia Pharma U.S. | Meals · 2025-09-11 | Lupkynis | $125 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $122
| Amgen | Evenity | $122 | 1 payment
|
2022: $346
| Amgen | Prolia | $114 | 2 payments
|
| GlaxoSmithKline | Benlysta | $103 | 1 payment
|
| Radius Health | Tymlos | $100 | 1 payment
|
| Novo Nordisk | Ozempic | $28 | 1 payment
|
2021: $17
| Amgen | Evenity | $17 | 1 payment
|
2020: $81
| Amgen | Enbrel | $81 | 1 payment
|
2019: $94
| Gilead Sciences | None | $94 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1902240203
- Licence
- CA A133255California A133255: Current · expires 2028-08-31
- Trained
- University of California, Geffen School of Medicine, 2013
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Student in a training program (390200000X)
- Mailing address
- 5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
- NPI first listed
- 2013-04-17
- NPI last updated
- 2021-05-12
- NPI record certified
- 2021-05-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305